DUBUQUE, IA / ACCESSWIRE / March 14, 2024 / For many, group health insurance has become more overpriced and less…
Biotricity's AI automation engine has already proven to increase operational efficiency and support growth, evidenced by the Company's recent margin…
Provides update on two late-stage clinical programs for BXCL501 for potential treatment of agitation Recently completed meetings with U.S. Food…
Conference call and webcast: today, March 7, 2024, 9:00 am E.T. +1-888-407-2553 or +972-3- 9180608 I https://veidan.activetrail.biz/evogeneq4-2023 REHOVOT, Israel, March…
Ethics and regulatory approvals finalized for world-first take-home use of a psychedelic medicine MB22001 in placebo-controlled trial in depressed patients…
DUBLIN, Feb. 26, 2024 /PRNewswire/ -- The "Global Clinical Alarm Management Market by Product (Nurse Call Systems; Connectivity/Integration Software -…
BOSTON, Feb. 26, 2024 /PRNewswire/ -- Health Data Analytics Institute (HDAI) – a company pioneering the integration of artificial intelligence into healthcare…
Conference call scheduled for 9:00 AM ET REHOVOT, Israel, Feb. 26, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a…
SEOUL, SOUTH KOREA / ACCESSWIRE / February 13, 2024 / Chowis Company, a developer of skin, hair and scalp analysis…
Designation for BXCL701 in combination with a checkpoint inhibitor (CPI) for treatment of patients with metastatic SCNC with progression on…